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ADAR-mediated RNA editing suppresses sleep
by acting as a brake on glutamatergic synaptic
plasticity
J.E. Robinson1,2, J. Paluch3, D.K. Dickman3 & W.J. Joiner1,2,4,5
It has been postulated that synaptic potentiation during waking is offset by a homoeostatic
reduction in net synaptic strength during sleep. However, molecular mechanisms to support
such a process are lacking. Here we demonstrate that deficiencies in the RNA-editing gene
Adar increase sleep due to synaptic dysfunction in glutamatergic neurons in Drosophila.
Specifically, the vesicular glutamate transporter is upregulated, leading to over-activation of
NMDA receptors, and the reserve pool of glutamatergic synaptic vesicles is selectively
expanded in Adar mutants. Collectively these changes lead to sustained neurotransmitter
release under conditions that would otherwise result in synaptic depression. We propose
that a shift in the balance from synaptic depression towards synaptic potentiation in
sleep-promoting neurons underlies the increased sleep pressure of Adar-deficient animals.
Our findings provide a plausible molecular mechanism linking sleep and synaptic plasticity.
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C
hronically unfulfilled sleep need contributes to numerous
medical problems including depression, pain, hyperten-
sion, diabetes and cardiovascular disease1–6. On a shorter
timescale, even 1–2 nights of poor sleep result in attention deficits
that can prove costly, or even deadly, in situations in which
reaction time is critical7. Remarkably, despite decades of intense
study, the mechanisms that control sleep need and the cellular
functions that they fulfil are largely unknown. In recent years
much attention has focused on the hypothesis that sleep need
arises from an experience-dependent increase in net synaptic
strength during waking8. According to the same hypothesis, sleep
homeostatically reverses this increase to maintain average
synaptic strength within an optimal dynamic range for synaptic
plasticity. Although much experimental data support this
hypothesis, criticisms persist and detailed mechanistic support
for the proposed phenomenon is lacking9.
We set out to identify novel sleep-regulating genes in the
fruit fly, Drosophila melanogaster, due to the genetic tractability
of this organism as well as the striking parallels between
sleep/wake behaviour in flies and mammals, which suggest that
core functions of sleep are evolutionarily conserved. This
notion has been reinforced in recent years by identification of
sleep-regulating genes and signalling mechanisms in flies and
mice that are believed to share similar functions, including
cyclic AMP signalling, voltage-gated Kþ channels, and
dopamine among others10. Notably lacking, however, have
been molecular discoveries relating sleep to defined forms of
synaptic plasticity.
We hypothesized that if sleep is indeed functioning to maintain
overall synaptic strength within a physiological range, then
identifiable genes should exist that reflect the reciprocal relation-
ship between both processes. For example, if net potentiation
during waking truly drives the need to sleep, then genetic lesions
resulting in increased synaptic strength should cause an increase
in sleep, whereas genetic lesions resulting in decreased synaptic
strength should cause a decrease in sleep. Finally, we reasoned
that the resulting dysregulation should shed light on the
mechanistic relation between synaptic plasticity and sleep, for
which very little information is currently known.
To test these ideas we performed a genetic screen in Drosophila
and found that the RNA-editing gene Adar is required for flies to
maintain normal waking. Consistent with a related role in
synaptic plasticity, Adar acts as a brake on sleep-promoting
glutamatergic signalling through postsynaptic AMPA and NMDA
receptors by reducing the reserve pool (RP) of synaptic vesicles
available for release during sustained trains of neuronal activity.
We therefore conclude that Adar suppresses sleep in Drosophila
by negatively regulating short-term potentiation.
Results
ADAR is required for wake maintenance. We systematically
screened for neuronal genes that control sleep need in
D. melanogaster and tested to what extent their mechanisms of
action involve synaptic plasticity. Our approach involved
coupling the GAL4/UAS system11 to RNA interference (RNAi)-
dependent knockdown of genetic targets specifically in the
nervous system and then assaying for effects on daily sleep.
After retesting promising lines, we found that efficient
knockdown of the conserved RNA-editing gene Adar
(Adenosine deaminase acting on RNA) led to increased sleep in
both male and female animals (elav4Adar RNAi; Fig. 1a–c;
Supplementary Fig. 1a,b; Supplementary Fig. 2a), an effect that
was recapitulated with a hypomorphic Adar allele (Adarhyp)12
that expresses just 20% of normal ADAR protein (Fig. 2a,b).
Consistent with a deficit in sleep/wake control rather than in
locomotion, Adar-deficient animals were at least as active during
waking as controls (Fig. 1d; Supplementary Fig. 1c) and had
inactive periods that could be fully overcome by mechanical
agitation (Fig. 1e). To determine which component of sleep/wake
control is regulated by Adar, we analysed the durations of both
sleep and wake bouts and found that depletion of Adar selectively
affected the latter, leading to destabilization of the waking state
(Fig. 1f,g; Supplementary Fig. 1d,e).
Two possible explanations for the increase in sleep caused by
reduction in Adar are altered sleep homoeostasis and increased
sleep pressure. To discriminate between these possibilities we
sleep-deprived Adar hypomorphs and control flies during the
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Figure 1 | Adar stabilizes the waking state to suppress sleep. (a) Representative sleep profiles of male elav4Adar RNAi and controls. (b) Quantification
of sleep in a. Pan-neuronal knockdown of Adar increases sleep in elav4RNAi animals relative to controls. (c) Representative western blot of fly brains
indicates efficient knockdown of ADAR expression in elav4Adar RNAi flies. (d) Waking activity is not reduced in elav4Adar RNAi animals. (e) Sleep in
elav4Adar RNAi animals is acutely reversible by mechanical perturbation. (f) Sleep maintenance is unaffected in elav4Adar RNAi animals. (g) The wake
state is destabilized in elav4Adar RNAi animals relative to controls. For each panel: elav4þ (n¼ 39); elav4Adar RNAi (n¼ 54); þ4Adar RNAi (n¼ 39).
For all figures *, **, *** and **** indicate Po0.05, 0.01, 0.001 and 0.0001, respectively, and error bars represent s.e.m.
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final 4 h of night and measured homoeostatic recovery sleep the
next morning. We found that both groups of animals recovered
B1.5 h of lost sleep and then returned to baseline levels in the
following days (Fig. 2c–g). We interpret these data to indicate that
depletion of Adar does not affect sleep homoeostasis. Although
we acknowledge that alternative interpretations are possible if the
rate of recovery of lost sleep is considered (Supplementary
Fig. 3a–c), we believe the most parsimonious interpretation of our
data are that Adar is required for normal sleep pressure, and that
in Adar mutants this process is decoupled from compensatory
homoeostatic mechanisms that would otherwise fix total daily
sleep at normal levels.
ADAR suppresses glutamatergic signalling. Previous studies in
Drosophila have suggested that ADAR protein is expressed
broadly throughout the brain12. To map where Adar functions
to modulate sleep behaviour, we initially performed an
anatomical screen in which we coupled UAS-Adar RNAi to a
variety of well-characterized GAL4 drivers that express in
populations of circadian clock neurons, established sleep-
regulating regions of the brain, and in neurons distinguishable
from one another by their distinct neurotransmitter systems
(Supplementary Table 1). We also screened an additional
collection of B500 randomly selected GAL4 lines derived
from cloned putative enhancer fragments13. Out of both
collections, the GAL4 driver 40B03 was most effective at
recapitulating the increase in sleep observed with pan-neuronal
knockdown of Adar (Supplementary Fig. 4).
As controls to confirm that knockdown of Adar by 40B03-
Gal4 led to increased sleep, rather than a physical disability or
generalized defect in CNS function, we performed a series of
additional experiments. In the first, we measured the respon-
siveness of knockdown animals to an arousal stimulus of fixed
intensity. Consistent with the rapidly reversible nature of sleep,
we found that the tendency of 40B034Adar RNAi flies to
remain immobile could be fully overcome by mechanical
stimulation (Supplementary Fig. 5a). In a second experiment,
we fed flies with the caffeine analogue, IBMX, and found that it
was able to efficiently maintain waking in 40B034Adar RNAi
animals (Supplementary Fig. 5b). In a third experiment, we
tested climbing ability and found that 40B034Adar RNAi flies
showed no performance deficits relative to controls
(Supplementary Fig. 5c). In a fourth experiment, we tested
whether increased sleep in 40B034Adar RNAi animals occurs
through effects on selected neuronal circuits or through a
general depression of neuronal function. We reasoned that
widespread effects should sensitize animals to other general CNS
depressants. To test this possibility we measured the amount of
time it took for flies to stop responding to a repeated mechanical
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Figure 2 | Reducing Adar levels does not alter sleep homeostasis. (a and b) Representative sleep profiles (a) and total daily sleep (b) for Adarhyp and
sibling control animals (females; Adarhyp (n¼ 93); control (n¼ 95)). (c and d) Representative sleep profiles during baseline, deprivation (red bar; ZT20–24)
and recovery periods for sibling control (c) and Adarhyp animals (d). (e and f) Quantification of sleep lost during deprivation period (e) and recovered the
next morning from ZT0–6 (f). (g) Total sleep each day from ZT0–6. Sleep returns to baseline after 1 day of recovery. (In c–g: Adarhyp (n¼90); control
(n¼95)). In this figure, control refers to siblings of Adarhyp animals outcrossed into a w1118 genetic background. Females were used for all sleep
homoeostasis experiments.
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stimulus in the presence of volatilized ethanol. We found that
40B034Adar RNAi flies had normal sensitivity and develop-
ment of tolerance to ethanol (Supplementary Fig. 5d),
suggesting that Adar selectively modulates neural circuitry
involved in sleep regulation rather than acting as a global gain
control of brain activity.
We also tested the role of 40B03 neurons in regulating sleep by
increasing their electrical excitability with the bacterial sodium
channel, NaChBac (ref. 14). We found that 40B034NaChBac
flies had increased sleep compared with controls (Fig. 3a), similar
to what we observed in 40B034Adar RNAi animals. Our data
thus suggest that 40B03 neurons promote sleep and that Adar
suppresses output of these neurons.
To continue to address where Adar functions to regulate
sleep, we then coupled 40B03-Gal4 to UAS-CD8::GFP
(40B034CD8GFP) and examined whole mounts of dissected
brains by confocal microscopy (Fig. 3b). Although
40B034CD8GFP expression was restricted to a subset of neurons
in the fly brain, we were unable to correlate specific cell types with
sleep function. Notably, 40B03 expresses in a number of Kenyon
cells comprising part of the mushroom bodies, which have been
previously implicated in sleep15,16. However, ADAR protein does
not appear to express in adult Kenyon cells12, and we do not
observe changes in sleep after expressing Adar RNAi in the
mushroom bodies using commonly used GAL4 drivers
(Supplementary Table 1). The increased sleep we observed
upon pan-neuronal knockdown of Adar suggested a nervous
system requirement for this molecule, and indeed we also found
that the neuronal suppressor of GAL4 activity, elav-Gal80,
blocked the ability of 40B034Adar RNAi to increase sleep. In
contrast, the cholinergic-specific suppressor of GAL4 activity,
cha-Gal80, had no effect on sleep in 40B034Adar RNAi animals
(Fig. 3c), suggesting a non-cholinergic role for Adar in sleep
regulation. Thus, despite the fact that RNA editing alters the
identities of thousands of transcripts17,18, our ability to map the
effect of this process to non-cholinergic neurons suggested
that specific cellular mechanisms might mediate Adar’s effects
on sleep.
Elevated DVGLUT and NMDAR activity increase sleep. Since
Adar is known to alter synaptic transmission by unresolved
mechanisms at the neuromuscular junction (NMJ)19, which is
glutamatergic in flies, we hypothesized that Adar’s effects on sleep
might be mediated by alterations in glutamatergic signalling in
the central brain. To test this hypothesis, we compared sleep in
Adar null mutants (AdarP)20 alone and in the presence of
transgenic Adar expressed exclusively in glutamatergic neurons
(AdarP;OK3714Adar). As expected, AdarP mutants exhibited an
increase in sleep, and this phenotype was significantly attenuated
in AdarP;OK3714Adar animals (Fig. 3d). Thus, Adar expression
in glutamatergic neurons is sufficient to restore nearly normal
sleep to Adar-deficient animals.
Together with evidence that synaptic vesicles accumulate at the
NMJ in Adar mutants19, these data prompted us to measure
protein levels of the Drosophila vesicular glutamate transporter
(DVGLUT) in fly heads. Consistent with a defect in synaptic
signalling in central glutamatergic neurons, we found a striking
increase in DVGLUT protein in flies depleted of Adar (Fig. 4a;
Supplementary Fig. 2b). To determine whether this increase was
responsible for the increase in sleep we observed in Adar-deficient
animals, we paired Adar hypomorphs with a single copy of either
a strong hypomorphic or a null dvglut allele21. On their own,
neither of the heterozygous dvglut alleles affected sleep, but we
found that each one was able to suppress the excess sleep of Adar
hypomorphs (Fig. 4b). Thus, compensating for elevated
DVGLUT restores normal sleep to Adar-deficient animals.
Interestingly, even more severe reductions in dvglut expression
led to significantly less sleep than in controls (Supplementary
Fig. 6), suggesting that levels of glutamatergic signalling must be
tightly maintained within a narrow range to avoid excesses and
shortfalls in daily sleep.
To determine the identities of postsynaptic mediators of
increased glutamatergic signalling in Adar-deficient animals, we
knocked down various glutamate receptor transcripts in the fly
genome while simultaneously reducing Adar expression
(Supplementary Fig. 7). Interestingly, knockdown of either of
two NMDA-type glutamate receptors, NR1 or NR2, was sufficient
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Figure 3 | Adar suppresses output of glutamatergic sleep-promoting neurons. (a) Total daily sleep is increased in flies expressing the depolarizing
NaChBac channel under control of 40B03-Gal4 (40B034þ (n¼ 24); 40B034NaChBac (n¼ 30); þ4NaChBac (n¼ 31)). (b) Representative expression
pattern of 40B034CD8GFP (green) and of the neuropil marker, nc82 (magenta), in central brain and thoracic ganglion. Scale bars, 57 mm. (c) Increased
sleep in 40B034Adar RNAi animals is suppressed by pan-neuronal (elav) but not cholinergic (cha) expression of GAL80 (n¼ 23–48 for each genotype).
(d) Restoration of Adar expression in glutamatergic neurons (OK371-Gal4) restores sleep to control levels in Adar null mutants (AdarP; n¼ 23–32 for each
genotype).
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to partially or completely restore normal sleep to animals
depleted of Adar. Similar results were obtained with two
independent NR2 RNAi lines (Fig. 4c). Since activation of
NMDA receptors is known to require simultaneous
synaptic release of glutamate and depolarizing current through
AMPA-type glutamate receptors, AMPA receptor signalling
would also be expected to be involved in Adar-dependent
increases in sleep. Consistent with this expectation, we observed
restoration of normal sleep to Adar-deficient animals on
knockdown of the AMPA receptor transcript GluRI
(Supplementary Fig. 7). Thus, Adar is required to reduce
signalling through excitatory glutamate receptors in the brain.
An expanded RP increases sleep in Adar mutants. Enhanced
excitatory glutamate signalling through AMPA/NMDA receptors
could be achieved through several distinct mechanisms related to
elevated DVGLUT expression. First, each synaptic vesicle could
contain more DVGLUT, thus increasing the amount of glutamate
packaged into each vesicle, which would result in an increase in
quantal size22. In the absence of accessible and relevant neurons
in the adult central nervous system from which to characterize
synaptic properties, we tested this possibility by measuring
spontaneous miniature excitatory postsynaptic potentials
(mEPSPs) at the larval glutamatergic NMJ, which is a model
for central glutamatergic synaptic transmission. In this
preparation, a null allele of Adar has been reported to exhibit
increased mEPSP amplitude19. However, these changes were not
detectable with more moderate reductions in Adar that are still
able to increase sleep (Figs 5a–c; 2a,b). Second, more vesicles
could be released per action potential that arrives at presynaptic
terminals. However, we did not measure a difference in quantal
content in Adar hypomorphs relative to controls, as reflected in
the amplitude of evoked EPSPs at the NMJs of both groups of
animals (Fig. 5d–f). These data strongly suggest that reductions in
Adar that are sufficient to increase sleep do not alter the amount
of glutamate in each synaptic vesicle or the number of vesicles
released per action potential during baseline synaptic
transmission.
These measurements also permitted us to clearly distinguish
changes in synaptic vesicle size and number from potential
expansions or contractions of different vesicle pools that could
alternatively underlie constitutive potentiation of glutamatergic
synapses. Specifically, we hypothesized that the increased sleep
observed in Adar-depleted flies was mediated by an increase in
availability of glutamatergic vesicles during sustained neuronal
activity. In support of this hypothesis, a previous study reported
that Adar mutants accumulate synaptic vesicles and vesicle-
related proteins at the NMJ19. We also tested our hypothesis by
stimulating axons at the NMJ for 10min at 15Hz to deplete
synaptic vesicle pools while measuring the quantal content per
stimulus (Fig. 6a). As described by others, we found that change
in quantal content followed two temporally distinct phases: an
initial period involving rapid decay followed by a subsequent
period of slower, more sustained decay. Such changes have been
attributed to fast and slow depletion of what are often referred to
as the readily releasable pool (RRP) and RP of synaptic vesicles,
respectively23. Intriguingly, in Adar hypomorphs with increased
sleep we found that the fast phase decayed more quickly (Fig. 6b)
and the slow phase decayed more slowly than in controls
(Fig. 6c). These data are consistent with both an expanded RP in
Adar mutants and chronically potentiated glutamatergic
signalling, which could be a signal to sleep.
To determine whether our observations at the larval NMJ were
relevant to altered sleep in Adar-deficient adults and whether a
larger RP size was responsible for the increase in sleep we
observed in Adar mutants, we focused on the possible genetic
interaction between Adar and Synapsin (Syn). Syn encodes a
synaptic vesicle protein that is thought to act as a barrier to
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Figure 5 | Adar hypomorphs have normal spontaneous and evoked
synaptic transmission at the NMJ. (a) Representative recordings of
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transitions from the RP to the RRP24. A reduction in the amount
of Syn should thus lower the barrier to this transition. By this
logic, if increased sleep in Adarmutants results from an expanded
glutamatergic RP, then reducing the levels of Syn should
compensate for this effect. To test this hypothesis we coupled a
hypomorphic mutation in Adar that increased sleep with a
heterozygous null mutation in Syn (Syn97; ref. 25) and measured
rates of depletion of the RP and RRP during high-frequency
presynaptic stimulation of the NMJ. Consistent with our
hypothesis, the rate of depletion of the RP was restored nearly
to control levels in Adarhyp;;Syn97/þ double mutants without
altering the rate of depletion of the RRP (Fig. 6b,c). We then
reasoned that if an expanded glutamatergic RP indeed increases
sleep need, then restoring the size of the RP to normal by
reducing levels of Syn should also restore normal levels of sleep to
Adar mutants. To test this hypothesis, we measured total daily
sleep in animals containing Adarhyp alone or in combination with
the heterozygous Syn97 allele. Consistent with our hypothesis,
sleep was fully restored to control levels in Adarhyp;;Syn97/þ
mutants. Importantly, sleep was not reduced by heterozygous
Syn97 alone, thus demonstrating a specific genetic interaction
between Adar and Syn (Fig. 6d). Together, these data strongly
suggest that Adar normally restricts the size of the RP, thus
reducing glutamatergic synaptic potentiation via downstream
NMDAR signalling, which in turn limits sleep pressure. In the
absence of Adar, this brake on synaptic potentiation appears to be
released in sleep-promoting neurons, thus leading to increased
sleep pressure.
Discussion
By describing a role for Adar in suppressing sleep, we have
discovered a mechanistic link between sleep and synaptic
plasticity. Such a link has been hypothesized for many years
but has lacked molecular details to support it8,9. To arrive at this
link, we initially identified Adar as a sleep-regulating gene
through a genetic screen, mapped the hypersomnolence of Adar
mutants to sleep-promoting glutamatergic neurons, showed that
this phenotype was associated with an increase in DVGLUT, and
found that it could be compensated by genetic reductions in
dvglut, NR1, NR2 and GluRI. Collectively, these data suggest that
Adar normally suppresses glutamatergic signalling to reduce
sleep.
On the basis of our results, this signalling pathway appears to
be at least as important as other arousal systems in regulating
sleep. For example, previous reports have shown that overall
dopamine, octopamine and acetylcholine promote waking in
flies26–31, whereas serotonin predominantly promotes sleep32.
Similar to these neurotransmitters, we found that availability of
glutamate correlates with arousal state, wherein elevated
glutamate promotes sleep and reduced glutamate leads to
increased waking. Thus, it is likely that glutamatergic signalling
is tightly regulated to maintain proper levels and timing of
sleep—a process in which we have now implicated Adar.
In elucidating the pathway through which Adar acts to regulate
sleep, we found two points at which synaptic plasticity might be
implicated. The first is based on our observation that the
sleep-promoting effects of Adar mutants require AMPA and
NMDA receptors. NMDA receptors are frequently involved in
synaptic plasticity33–35, making them prime candidates for
potentiated synaptic responses that have been proposed to
accumulate during waking and in turn drive compensatory
sleep need. In fact, a recent report has described NR1 as a novel
sleep-promoting gene in Drosophila36. Here we have confirmed
that NMDA receptors promote sleep, and we have demonstrated
that they are required for the sleep phenotype of Adar mutants.
Thus, it is likely that a major role of wild-type Adar is to act
as a presynaptic brake on NMDA-dependent postsynaptic
potentiation.
We were able to more thoroughly investigate the second
mechanism by which Adar appears to regulate glutamatergic
synaptic plasticity to influence sleep. In this case, we found that
basal synaptic transmission in glutamatergic neurons was not
altered by depletion of Adar. That is, Adar hypomorphs had
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NMJ causes a faster rate of depletion of the RRP (inset) and a slower rate of depletion of the RP (main figure) in Adarhyp mutants relative to controls.
Heterozygous loss of Synapsin only rescues changes in the reserve pool (control (n¼8); Adarhyp (n¼ 6); Adarhyp;;Syn97/þ (n¼ 6)). (b) Quantification of
the decay rate of the RRP in a. Tau values are based on an exponential fit to the change in quantal content over time, ending at 1.0 s (control (n¼8); Adarhyp
(n¼6); Adarhyp;;Syn97/þ (n¼6)). (c) Quantification of the decay rate of the reserve pool. Values are based on linear regression fit of changes in quantal
content over time, beginning at 60 s (control (n¼ 8); Adarhyp (n¼6); Adarhyp;;Syn97/þ (n¼6)). (d) Heterozygous loss of Synapsin restores normal sleep
to Adarmutants (black bars) without altering sleep in controls (white bars; n¼45–48 for each genotype). In a–d, control refers to animals harbouring wild-
type Adar and wild-type Syn alleles in the same w1118 genetic background as both mutants.
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normal glutamate loading into synaptic vesicles, postsynaptic
responses to spontaneously released glutamate, and number of
glutamatergic vesicles released per evoked excitatory postsynaptic
potential. However, upon sustained stimulation, Adar mutants
exhibited decreased synaptic depression that could be compen-
sated by reducing Syn, a gene that limits depletion of the RP24.
Notably, reducing Syn was also sufficient to reduce sleep in Adar
mutants to control levels. Our data thus support the hypothesis
that Adar mutants have an expanded synaptic RP, which reduces
depression of sleep-promoting glutamatergic neurons to increase
intrusions of sleep into the waking state.
Expansion of the RP of synaptic vesicles, like those we have
observed in Adar mutants, has been shown to substantially
increase the amount of information transmitted per burst of
action potentials due to decreased short-term depression37. In
essence, this phenomenon shifts the balance of depression and
potentiation towards the latter. We suggest that in glutamatergic
sleep-promoting neurons, this shift translates to an increased
probability of sleep onset from spike trains that would normally
be sub-threshold for the behaviour.
Although our study fleshes out mechanistic details linking
modulation of short-term plasticity to sleep, hints of such a
connection exist from other studies as well. For example, loss-
of-function mutations in the Fragile X mental retardation 1
(Fmr1) gene cause an expansion of total synaptic vesicles in
mice38 and an increase in sleep in Drosophila39. Conversely, loss
of calcineurin impairs synaptic vesicle recycling in mice,
resulting in enhanced synaptic depression40, and causes
reduced sleep in Drosophila41,42. Although these effects and
our own findings are consistent with a positive correlation
between short-term synaptic potentiation and sleep, other
findings suggest a more complex relationship. For example,
loss of Rab3a in mice reduces the probability of synaptic vesicle
release following a train of action potentials43, thereby
increasing synaptic depression, and increases non-REM
sleep44. In addition, loss of the Rab3-interacting molecule
RIM1a reduces presynaptic calcium influx in mice, thereby
increasing short-term facilitation45, and reduces REM sleep46.
Rab3a and RIM1a mutant mice have other phenotypes as well,
thus complicating the establishment of a clear relationship
between short-term plasticity and sleep. Nonetheless, although
the directionality of change for each phenomenon may depend
on which neural circuits are impacted, there is ample evidence
linking short-term plasticity and sleep in various genetic
perturbations. Our own findings underscore this idea.
It will be interesting to determine if similar mechanisms link
sleep to potentiating responses involved in other forms of
behavioural plasticity. The link between RNA editing and
glutamatergic plasticity that we have described may be particu-
larly fruitful to explore in other contexts as well. Hints of such a
relationship have been described previously. For example, early
observations of the role of RNA editing in the brain showed that
ADAR functions postsynaptically to limit Ca2þ permeability and
channel conductance of GluR2-containing receptors47,48.
Furthermore, editing of GluR2, GluR3 and GluR4 at the R/G
position has been shown to alter receptor gating kinetics,
resulting in more rapid desensitization and recovery from
desensitization49. Together with evidence that RNA editing is
reduced in glutamate excitotoxic diseases such as ALS50–52, we
suggest that a major function of RNA editing in the nervous
system is to limit glutamatergic signalling. Since we have shown
that ADAR acts as a presynaptic glutamatergic brake in flies, it
will be interesting to determine whether this function is
conserved in mammalian nervous systems and whether ADAR
is also able to achieve the same effect through postsynaptic
regulatory mechanisms.
Methods
Fly stocks. D. melanogaster were grown at room temperature (20–22 C) on
standard cornmeal media with yeast. Unless otherwise indicated, all animals were
outcrossed a minimum of 5 times into a w1118 iso31 genetic background. AdarHA
and Adarhyp were obtained from Dr. Robert Reenan. AdarP and UAS-Adar were
obtained from Dr. Gabriel Haddad. dvglut1 and Df(2L)dvglut2 were obtained from
Dr. Aaron DiAntonio. The Adar RNAi line, 7764, was obtained from the Vienna
Drosophila Resource Center (http://stockcenter.vdrc.at/control/main) and was
used in the presence of UAS-Dicer in all experiments. UAS-CD8::GFP, UAS-Dicer
(second and third chromosome insertions), elav-Gal4, dvglutMI02805, OK371-Gal4,
Syn97, NR1 RNAi (HMS02200), NR2 #1 RNAi (HMS02012), NR2 #2 RNAi
(HMS02176), GluRI RNAi (HMS02155), GluRIB RNAi (JF02752), GluRIIA RNAi
(JF03145), GluRIIB RNAi (JF03145), GluRIIC RNAi (JF01854), GluRIID RNAi
(JF02035), GluRIIE RNAi (JF01962), Clumsy RNAi (JF02987), CG3822 RNAi
(JF01873), CG5621 RNAi (JF01840) and CG11155 RNAi (JF03425), mGluRA RNAi
(JF01958; refs 53,54), 40B03-Gal4 and all other Gal4 lines13 were obtained from the
Bloomington Stock Center (http://flystocks.bio.indiana.edu/). Male flies were used
for all behavioural assays unless otherwise indicated.
Sleep and locomotor measurements. Individual 3–7-days old flies were placed in
5 65-mm Pyrex tubes containing a mixture of 2% agarose and 5% sucrose at one
end as a food source. Animals were entrained for 2 days in 12 h:12 h light:dark
conditions at 25 C, and infrared beam breaks were recorded in 1min bins for the
next 2–4 days using the Drosophila Activity Monitoring System (Trikinetics). Sleep
analysis was performed as previously described using custom MATLAB (Math-
works) software30. For IBMX treatment, 1 day of baseline sleep was recorded on
standard food before animals were moved at ZT0 into new glass tubes containing
food supplemented with 0.1mgml 1 IBMX (Sigma). Sleep was calculated for the
second day on drug.
Sleep deprivation and rebound. Flies in DAM2 Drosophila activity monitors
(Trikinetics) were sleep deprived by periodic shaking in a VX-2500 multi-tube
vortexer (VWR) for 2 smin 1 from ZT20–24. Animals were deprived of sleep for
4 h because this duration was found to be sufficient to elicit saturating levels of
rebound without physically damaging animals. Rebound sleep was measured as
immediate post-deprivation minus pre-deprivation sleep at ZT0–6.
Sleep reversibility measurements. Flies were loaded into DAM2 activity
monitors and placed on a custom built platform that oscillated along a line
perpendicular to the axis of locomotion. Oscillation speed and timing were
controlled using an Arduino Uno-powered motor. Arousal stimuli consisted of 10 s
oscillations every minute for 5min at ZT0–6. Sleep was considered to be reversible
for any fly that moved within 5min of the final stimulation. Dead flies were also
included as negative controls to rule out spurious detection of activity due to
involuntary motion across the infrared beam.
Climbing assays. Three to seven-day old flies were transferred at ZT2 to two
empty vials (25 95mm) connected to each other vertically at their open ends.
After 10min acclimation, flies were tapped to the bottom of the lower vial. After
30 s a divider was placed between the vials and the percentage of flies that
successfully climbed into the upper vial was measured. Means for each genotype
were recorded after three trials.
Ethanol sensitivity and tolerance. Three to seven- day old flies were transferred
at ZT2 to empty vials and tested every minute for loss-of-righting reflex during
exposure to ethanol as previously described55. The time for 50% of the animals to
remain stationary (ST50) was measured. Continued exposure to ethanol was
maintained for approximately twice this time before transferring animals to a fresh
vial. After 4 h recovery, the same animals were transferred back to ethanol-
containing vials, and ST50 was measured again to determine ethanol tolerance.
Immunohistochemistry. Immunohistochemistry was performed as described
previously30. Briefly, 3–7-day old brains were dissected in ice-cold PBS, fixed in 4%
paraformaldehyde, and blocked in PBST (PBS and 0.3% Triton X-100) with 5%
normal donkey serum (Jackson Laboratory) before staining. Brains were then
incubated with 1:1,000 rabbit anti-GFP (Invitrogen) and 1:50 mouse anti-nc82
(Developmental Studies Hybridoma Bank) antibodies overnight at 4 C and
washed five times in PBST. Brains were then incubated with 1:1,000 Alexa
568 anti-rabbit (Life Technologies) and 1:1,000 Alexa 633 anti-mouse
(Life Technologies) antibodies for 4 h at room temperature before washing five
times in PBST and coverslip mounting in Vectashield (Vector Labs). Images were
taken at  40 magnification on a Leica SP5 confocal microscope at 0.5mm
intervals and reassembled for display as maximum projections using Fiji56.
Western blot analysis. Brains or heads (15–20) were dissected from 3–7-day old
flies and lysed in sample buffer (20mM HEPES, pH 7.5, 100mM KCl, 10mM
EDTA, 50mM NaF, 0.1% Triton X-100, 10% glycerol, 1mM DTT, 1X Roche
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Complete Protease Inhibitors). Lysates were cleared of particulate debris by
centrifugation at 5,000g for 5min at 4 C before protein quantification. Lysates
were resolved on 10-wells 4–12% NuPAGE SDS-PAGE gels (Invitrogen) and
transferred to nitrocellulose membranes. Membranes were probed using 1:500
mouse anti-HA (Covance), 1:10,000 rabbit anti-DVGLUT22 and 1:10,000 mouse
anti-actin primary antibodies (EMD Millipore) followed by 1:5,000 anti-mouse,
1:5,000 anti-rabbit and 1:10,000 anti-mouse HRP antibodies, respectively (VWR).
Visualization of bound secondary antibodies was achieved using SuperSignal West
Pico Chemiluminescent Substrate (Thermo Scientific). Images in the main figures
have been cropped for presentation. Full size images are presented in
Supplementary Fig. 2.
Electrophysiology. All dissections and recordings were performed in modified
HL3 saline57 containing (in mM): 70 NaCl, 5 KCl, 10 MgCl2, 10 NaHCO3, 115
Sucrose, 5 Trehelose, 5 HEPES and 0.4 CaCl2 (unless otherwise specified), pH 7.2.
Neuromuscular junction sharp electrode (electrode resistance between 10 and
35MO) recordings were performed on muscles 6 and 7 of abdominal segments A2
and A3 in wandering third instar larvae. Larvae were cultured in standard molasses
medium, raised at 25 C and dissected; the guts, trachea and ventral nerve cord
were removed from the larval body walls with the motor nerve carefully cut, and
the preparation was rinsed several times with HL3 saline. Recordings were
performed on an Olympus BX51 WI microscope using a  40/0.80 water-dipping
objective. Recordings were acquired using Axoclamp 900A amplifier, Digidata
1440A acquisition system and pClamp 10.5 software (Molecular Devices).
Electrophysiological sweeps were digitized at 10 kHz, and filtered at 1 kHz. Data
were analysed using Clampfit (Molecular devices), MiniAnalysis (Synaptosoft) and
Excel (Microsoft).
mEPSPs were recorded in the absence of any stimulation, and cut motor axons
were stimulated atB5 nA for 3ms to elicit EPSPs. To fine tune stimulus intensity,
an ISO-Flex stimulus isolator was used (A.M.P.I.). Intensity was adjusted for each
cell, set high enough to consistently elicit full responses in both axons innervating
the muscle segment. Average mEPSP amplitude, EPSP amplitude, and quantal
content were calculated for each genotype with corrections for nonlinear
summation58. Muscle input resistance (Rin) and resting membrane potential (Vrest)
were monitored during each experiment. Recordings were rejected if the Vrest was
more depolarized than  60mV, if the Rin was less than 5MO, or if either
measurement deviated by more than 10% during the experiment. For synaptic
vesicle rundown experiments, postsynaptic responses for each preparation were fit
to a single exponential curve RRP or averaged into 30 s bins and fit from 60 s to
9min by linear regression (RP).
Data analysis and statistics. Replicates (n values) represent the number of
biological replicates for each experimental condition. Bar graphs depict the
mean±s.e.m., except for box and whisker plots, which depict the median (line),
25th to 75th percentiles (box) and minimum/maximum values (whiskers). Unless
otherwise indicated, datasets that approximate a normal Gaussian distribution were
analysed with unpaired Student’s t-test followed by Welch’s correction for
comparisons between two groups. For experiments of single factor design, we
analysed data using one-way analysis of variance followed by the Tukey–Kramer
test for multiple comparisons or Sidak’s multiple comparisons test for select
comparisons. Two-way analysis of variance followed by Sidak’s multiple compar-
isons test was used to analyse experiments of two-factor design. For datasets from
non-Gaussian distributions, comparisons were performed using Kruskal–Wallis
test followed by Dunn’s multiple comparisons test. All statistical tests were
two-sided and performed using Prism 6.0 f for Mac OS X (GraphPad Software).
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